Renaissance Technologies »

Mink Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Mink Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mink Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mink Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2025-09-30 $204k 15k 14.00

More positions owned by Renaissance Technologies

Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Roblox Corp Cl A (RBLX)
United Therapeutics Corporation (UTHR)
Verisign (VRSN)
Applovin Corp Com Cl A (APP)
Microsoft Corporation (MSFT)
Kinross Gold Corp (KGC)
Exelixis (EXEL)
Franco-Nevada Corporation (FNV)
Alphabet Cap Stk Cl A (GOOGL)
Gilead Sciences (GILD)
Doordash Cl A (DASH)
Hims & Hers Health Com Cl A (HIMS)
Reddit Cl A (RDDT)

View all positions for Renaissance Technologies

Top funds holding Mink Therapeutics

Vanguard Group
Longbow Finance SA
Renaissance Technologies
Geode Capital Management
BlackRock
UBS Group
Tower Research Capital
Covestor
Advisor Group Holdings
Morgan Stanley
Northwestern Mutual Wealth Management Company
Game Plan Financial Advisors
Bnp Paribas Arbitrage, Snc
Hartland & Co
Jpmorgan Chase & Co

View all funds holding Mink Therapeutics